These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 12386934

  • 1. Molecular control of lymphangiogenesis.
    Baldwin ME, Stacker SA, Achen MG.
    Bioessays; 2002 Nov; 24(11):1030-40. PubMed ID: 12386934
    [Abstract] [Full Text] [Related]

  • 2. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
    Partanen TA, Paavonen K.
    Microsc Res Tech; 2001 Oct 15; 55(2):108-21. PubMed ID: 11596156
    [Abstract] [Full Text] [Related]

  • 3. Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice.
    Veikkola T, Jussila L, Makinen T, Karpanen T, Jeltsch M, Petrova TV, Kubo H, Thurston G, McDonald DM, Achen MG, Stacker SA, Alitalo K.
    EMBO J; 2001 Mar 15; 20(6):1223-31. PubMed ID: 11250889
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Molecular control of lymphatic metastasis.
    Achen MG, Stacker SA.
    Ann N Y Acad Sci; 2008 Mar 15; 1131():225-34. PubMed ID: 18519975
    [Abstract] [Full Text] [Related]

  • 7. Mesenchymal expression of vascular endothelial growth factors D and A defines vascular patterning in developing lung.
    Greenberg JM, Thompson FY, Brooks SK, Shannon JM, McCormick-Shannon K, Cameron JE, Mallory BP, Akeson AL.
    Dev Dyn; 2002 Jun 15; 224(2):144-53. PubMed ID: 12112468
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.
    Krishnan J, Kirkin V, Steffen A, Hegen M, Weih D, Tomarev S, Wilting J, Sleeman JP.
    Cancer Res; 2003 Feb 01; 63(3):713-22. PubMed ID: 12566318
    [Abstract] [Full Text] [Related]

  • 10. New insights into the biology and pathology of the cutaneous lymphatic system.
    Hirakawa S, Detmar M.
    J Dermatol Sci; 2004 Jun 01; 35(1):1-8. PubMed ID: 15194141
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.
    Mäkinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, Pulkkanen KJ, Kauppinen R, Jackson DG, Kubo H, Nishikawa S, Ylä-Herttuala S, Alitalo K.
    Nat Med; 2001 Feb 01; 7(2):199-205. PubMed ID: 11175851
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Development of the lymphatic vascular system: a mystery unravels.
    Hong YK, Shin JW, Detmar M.
    Dev Dyn; 2004 Nov 01; 231(3):462-73. PubMed ID: 15376314
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D.
    McColl BK, Baldwin ME, Roufail S, Freeman C, Moritz RL, Simpson RJ, Alitalo K, Stacker SA, Achen MG.
    J Exp Med; 2003 Sep 15; 198(6):863-8. PubMed ID: 12963694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.